Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Hirsutism in teens is often due to polycystic ovarian syndrome and needs careful assessment and support.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

The article concludes that schoolchildren and adolescents experienced various skin issues during the COVID-19 pandemic, including acne from masks and other skin reactions from the virus and vaccines.

Adult women with acne in Iraq often have more severe symptoms and hormone-related issues than younger girls with acne.

A 13-year-old boy had a rare, stable type of hair loss with little chance of regrowth, but treatment is available for looks.

Alopecia causes emotional distress, and better psychological support is needed.

Medical care for transgender youth should be individualized and supportive.

Alopecia areata negatively affects family life, mental health, and quality of life in young people.

Some teenagers with anorexia nervosa have worse cognitive abilities, especially in visual and spatial tasks, and this is more common in those with a lower body weight.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Finasteride reduces Hidradenitis Suppurativa flare-ups in children and teens, but long-term safety is unknown.

Kids with alopecia areata may experience more stress but not necessarily feel more anxious or depressed than others.

Diagnose PCOS in teens using irregular periods and high androgen levels, not ultrasound.

PCOS affects about 6.3% of teens globally, and ongoing checks are advised for those with irregular cycles or high androgen levels.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Diagnosing PCOS in teenagers is hard because its symptoms often look like normal puberty, and there's a need for better diagnosis methods and agreement on criteria.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

Diagnosing PCOS in teenagers should focus on signs of excess male hormones and not rely solely on ovarian ultrasound or irregular periods, and should be reassessed in adulthood.

Oestrogen does not affect adrenal androgen levels in children and adolescents.

Hormone therapy can improve mental health and quality of life for people with gender dysphoria, but long-term effects need more research.

HAIR-AN syndrome is common in young women and can be effectively managed with a comprehensive treatment plan.

PCOS in teen girls should be managed with lifestyle changes and sometimes medication to improve symptoms and health.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

About 5% of Thai university girls aged 17-19 have polycystic ovary syndrome, with moderate acne being a strong risk factor.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Dermatologists should understand cultural practices and communicate empathetically to effectively treat skin conditions in children and teens of color.

Most skin conditions in Down syndrome are benign and involve dry or thickened skin.